Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Auric Goldfinger's Short List -- Ignore unavailable to you. Want to Upgrade?

To: RockyBalboa who wrote (7987)	7/16/2001 10:15:27 AM
From: Michael T Currie	Respond to of 19428

Why? Because your present leader can't admit that he jumped into what may be enventually a good short far, far too soon? Because your present leader is an abusive little smeghead who is obsessed with the word 'piker'? Or because he is unable to stop himself from posting abuse on other threads without reference to any stock i.e. purely for the abuse itself? Is that you think I need psychologic aid? You may now buy a clue.

To: RockyBalboa who wrote (7987)	7/20/2001 4:31:09 PM
From: Sir Auric Goldfinger	Read Replies (1) \| Respond to of 19428

PolyMedica Not Moving To NYSE >PLMD 2001-07-20 16:19 (New York) PolyMedica To Remain On NASDAQ WOBURN, Mass.--(BUSINESS WIRE)--July 20, 2001--PolyMedica Corporation (NNM: PLMD) today reported that it will not be listed on the New York Stock Exchange on July 23, 2001 as previously announced. The New York Stock Exchange notified the Company earlier this morning that it had changed it's decision to list the Company, but has not informed the Company of its reason for doing so. [hint: Govt Agency, 3 letters,& the first letter is not A,B, C, D or E] The New York Stock Exchange has informed the Company that it would be pleased to consider a new application from the Company. About PolyMedica (www.polymedica.com) PolyMedica is a rapidly growing national medical products and services company. The Company is best known through its Liberty Medical brand name and innovative direct-to-consumer television advertising to seniors with diabetes. Building on its technology-based operating platform and compliance management focus, PolyMedica has expanded its chronic disease business into the respiratory market. In addition, the Company's AZO line of products addresses female urinary tract discomfort, where it is the market leader, as well as symptoms of menopause and incontinence. PolyMedica is included in the Russell 2000 and S&P Small Cap 600 indices. This press release contains forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to risks and uncertainties, which could cause actual results to differ materially from those anticipated. Such risks and uncertainties include, but are not limited to, changes in Medicare reimbursement, fluctuations in customer demand, management of rapid growth, intensity of competition from other healthcare product vendors, timing and acceptance of new product introductions, general economic conditions and regulatory changes, as well as other especially relevant risks detailed in the Company's filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K for the period ended March 31, 2001 and the information set forth herein should be read in light of such risks. The Company assumes no obligation to update the information contained in this press release.